Triglyceride-Glucose Index in Diabetic Nephropathy in Type 2diaberes Mellitus Patients

Assiut University100 enrolled

Overview

The aim of the present study is to investigate the associations between the TyG index and diabetic nephropathy in patients with type2 DM .

the triglyceride-glucose (TyG) index was proposed as a simple and reliable surrogate marker of IR, and it has been reported to be closely correlated with the HOMA-IR index. The TyG index has the advantage of being applicable in clinical practice since both triglyceride and glucose levels are routinely measured and the cost of these measurements is low.

Study Type

OBSERVATIONAL

Enrollment

100

Conditions

Diabetes Mellitus, Type 2

Eligibility

Sex: ALLMin age: 25 YearsMax age: 75 Years

Medical Language ↔ Plain English

Inclusion Criteria: * patients with type 2 DM Exclusion Criteria: \- (1) Individuals with obstructive uropathy, severe heart failure, stroke, liver disease, cancer, autoimmune disease (2) Pregnant woman. (3)End stage renal disease patients on dialysis ( glomerular filtration rate \<15 mL/min/1.73 m2) or renal transplantation. (4) Type 1 Diabetic patient. (5) Albuminuria due to non-diabetic renal disease

Outcomes

Primary Outcomes

TyG index in type 2diaberes Mellitus

Detecting the association between the TyG index and diabetic nephropathy in type 2 diabetes

Time frame: Baseline

Central Contacts

Aya Abo Eyosr Garhey

CONTACT

01092606888 Ayayosry285@gmail.com

Salah Abdelazeem Argoon

CONTACT

01019683366 Argoons@yahoo.com

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.